Spring Newsletter- May
News & Updates 
Medication-Assisted Treatment (MAT)
Glossary- Register for
e-Notifications
of when site is updated. - Addiction Treatment Forum
is made possible by an unrestricted educational grant from Covidien Mallinckrodt, St. Louis, MO, a manufacturer of methadone and naltrexone.
-
This site complies to the HONcode standard for trustworthy health information: verify here. - Addiction Treatment Forum is produced by an independent medical communications agency. Commercial advertising is not accepted. See also, Contact Information, Terms of Use, and Privacy Policy.
- © Addiction Treatment Forum
Published by
Clinco Communications, Inc.
P.O. Box 685
Mundelein, IL 60060
Phone/Fax: 847-392-3937
E-mail to: Feedback@ATForum.com
Addiction Treatment Forum reports on substance abuse and addiction therapies, research, news, and events of interest to both healthcare professionals and patients
with a focus on Medication-Assisted Treatment (MAT) for opioid addiction.
Here's What's New...
Spring 2009 AT Forum Newsletter (Vol. 18, #2)
In This Issue
- From Publisher – Opioids + Benzodiazepines = Danger
- Mandatory QTc Screening for Methadone Patients – OTPs Respond to Published Guidelines
- Transforming New York’s OTPs into Addiction Recovery Centers - An Interview with OASAS Commissioner Karen M. Carpenter-Palumbo
- The Dangers of Benzodiazepine Abuse During MAT
- Overcoming Admission Barriers to MAT
- Events
Go to Current Newsletter PDF (HTML Version available)
New From SAMHSA - Emerging Issues in the Use of Methadone Advisory
This Spring, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued an 8-page advisory related to the increase in deaths related to methadone. For OTPs, the advisory discusses:
- Clinical issues related to risk factors in the treatment of opioid dependence.
- Improving patient safety in opioid addiction treatment.
The 8-page PDF is available here for download <click here…> (514KB, 8pp)